Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01982526

Enrollment

Registered

2013-11-13

Start date

2012-05-31

Completion date

2016-05-31

Last updated

2018-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrioma, Surgery

Keywords

Ovarian reserve, Antimullerian hormone

Brief summary

Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.

Detailed description

long term results of the postoperative follow up for the endometrioma patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

17 Years to 42 Years

Healthy volunteers

Yes

Inclusion criteria

* Ultrasonographical symptomatic and benign cysts which has surgery indication.

Exclusion criteria

* Over 42 years old, systemic endocrine disorder, history of ovarian surgery

Design outcomes

Primary

Measure	Time frame
Long term postoperative ovarian reserve outcomes of endometrioma patients by examining antimullerian hormone.	2 years

Countries

Turkey (Türkiye)

Outcome results